Blood Clots

Rates of anticoagulation therapy were higher for patients whose main reason for acute-care admission was Afib, yet only 50% of those patients initiated use.

The findings could having an impact on clinical practice and even alter the standard of care, say the authors of a study published Wednesday in the New England Journal of Medicine.

A large, new study published by the American Heart Association reveals the threat of blood clots leading to life-threatening strokes, heart attacks and pulmonary embolism can linger for nearly a year after...

Direct oral anticoagulants are linked to fewer readmissions for stroke and bleeding events when compared with warfarin, investigators say.

CDC considers updating mask guidance as states drop mandates … Clot-busting stroke drug safe to use in patients taking blood thinners … New questionnaire helps assess elders’ exercise motivation...

Many clinicians participating in the Medicare Part D program have continued to prescribe warfarin over direct-acting oral anticoagulants, despite evidence that the latter drugs are safer and more effective...

Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...

High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.

Patients who take anticoagulants before contracting COVID-19 are 43% less likely to be admitted to the hospital, and those who are given the drugs while hospitalized are less likely to die, according to...

Physicians appear to place lower importance on factors that may lead to diagnosis of pulmonary embolism when evaluating patients with dementia who present with shortness of breath, investigators say.